![Jeffrey Moore](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jeffrey Moore
Directeur/Membre du Conseil chez
MP Healthcare Venture Management, Inc.
Profil
Jeffrey Moore is currently serving as the President of MP Healthcare Venture Management, Inc. and as a Board Member of PharmEnable Therapeutics Ltd., Capsigen, Inc., and SOLA Biosciences LLC.
Previously, he worked as a Director at QurAlis Corp.
from 2018 to 2020.
He also held positions as a Principal at Millennium Pharmaceuticals, Inc., Scriptgen Pharmaceuticals, Inc., and RCT BioVentures.
Additionally, he served as a Board Member at Diamond Edge Ventures, Inc. Dr. Moore received his doctorate from the University of Oxford, his MBA from the Massachusetts Institute of Technology, and his undergraduate degree from the University of New Brunswick.
He also received a graduate degree from Harvard Medical School.
Postes actifs de Jeffrey Moore
| Sociétés | Poste | Début |
|---|---|---|
MP Healthcare Venture Management, Inc.
 MP Healthcare Venture Management, Inc. Investment ManagersFinance MP Healthcare Venture invests in companies located in the North America and Europe. The firm focuses on sectors such as biotechnology, biopharmaceuticals, therapeutics and diagnostics. It participates in seed and early stage capital transactions. | Directeur/Membre du Conseil | 01/01/2008 |
SOLA Biosciences LLC
 SOLA Biosciences LLC Pharmaceuticals: MajorHealth Technology Operates as a pre-clinical-stage biopharmaceutical company that develops gene-therapies for patients with neurodegenerative diseases | Directeur/Membre du Conseil | 01/09/2021 |
Capsigen, Inc.
 Capsigen, Inc. BiotechnologyHealth Technology Operates as a biotechnology firm that intends to engineer novel AAV capsids | Directeur/Membre du Conseil | 01/12/2020 |
Pharmenable Ltd.
 Pharmenable Ltd. Pharmaceuticals: MajorHealth Technology Operates as a drug discovery company | Directeur/Membre du Conseil | 01/11/2022 |
Anciens postes connus de Jeffrey Moore
| Sociétés | Poste | Fin |
|---|---|---|
QurAlis Corp.
 QurAlis Corp. Pharmaceuticals: MajorHealth Technology Develops precision medications | Directeur/Membre du Conseil | 01/04/2020 |
Diamond Edge Ventures, Inc.
 Diamond Edge Ventures, Inc. Investment ManagersFinance Diamond Edge Ventures invests in companies located across the globe. The firm focuses on a broad range of sectors and industries. It provides financing for early and later stage capital transactions. | Directeur/Membre du Conseil | - |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Corporate Officer/Principal | - |
Scriptgen Pharmaceuticals, Inc.
 Scriptgen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops small molecule drugs | Corporate Officer/Principal | - |
RCT BioVentures
 RCT BioVentures Investment ManagersFinance RCT BioVentures invests in companies located in the United States. The firm targets companies operating in the fields of biotechnology, medical devices & technology sectors. It provides financing for early stage capital requirements. | Corporate Officer/Principal | - |
Formation de Jeffrey Moore
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
89
Relations au 1er degré
13
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 13 |
|---|---|
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Health Technology |
Scriptgen Pharmaceuticals, Inc.
Scriptgen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops small molecule drugs | Health Technology |
University of Oxford
 University of Oxford Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
RCT BioVentures
RCT BioVentures Investment ManagersFinance RCT BioVentures invests in companies located in the United States. The firm targets companies operating in the fields of biotechnology, medical devices & technology sectors. It provides financing for early stage capital requirements. | Finance |
Massachusetts Institute of Technology
 Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
University of New Brunswick
 University of New Brunswick Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
MP Healthcare Venture Management, Inc.
MP Healthcare Venture Management, Inc. Investment ManagersFinance MP Healthcare Venture invests in companies located in the North America and Europe. The firm focuses on sectors such as biotechnology, biopharmaceuticals, therapeutics and diagnostics. It participates in seed and early stage capital transactions. | Finance |
Harvard Medical School
 Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
QurAlis Corp.
QurAlis Corp. Pharmaceuticals: MajorHealth Technology Develops precision medications | Health Technology |
Diamond Edge Ventures, Inc.
Diamond Edge Ventures, Inc. Investment ManagersFinance Diamond Edge Ventures invests in companies located across the globe. The firm focuses on a broad range of sectors and industries. It provides financing for early and later stage capital transactions. | Finance |
Pharmenable Ltd.
Pharmenable Ltd. Pharmaceuticals: MajorHealth Technology Operates as a drug discovery company | Health Technology |
Capsigen, Inc.
Capsigen, Inc. BiotechnologyHealth Technology Operates as a biotechnology firm that intends to engineer novel AAV capsids | Health Technology |
SOLA Biosciences LLC
SOLA Biosciences LLC Pharmaceuticals: MajorHealth Technology Operates as a pre-clinical-stage biopharmaceutical company that develops gene-therapies for patients with neurodegenerative diseases | Health Technology |
Choisissez Zonebourse 
